Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-07

Clinical Trial Update: Upright MRI for Prostate Cancer Screening

View source ↗

Summary

The study is evaluating upright MRI as a screening tool for prostate cancer in men with elevated PSA. Recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Prostate Cancer, Elevated PSA | Status: RECRUITING